- Protein Name
- Serine/threonine-protein kinase TAO2
- Gene Name
- Taok2
- Organism
-
Rattus norvegicus
- Function
- Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. May affect microtubule organization and stability. May play a role in the osmotic stress-MAPK8 pathway. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14/p38 MAPK activation.
Site |
Maximum Consensus Site Population |
Minimum Consensus Site Population |
Median Consensus Site Population |
MPP |
13 |
4 |
6.0 |
DFG |
15 |
3 |
4.5 |
DRS |
20 |
2 |
12.0 |
MT3 |
11 |
3 |
8.0 |
CMP |
8 |
6 |
7.0 |
PDIG |
18 |
3 |
16.0 |
ATP |
14 |
4 |
10.0 |
PDB ID |
Maximum Consensus Site Population |
MPP site |
DFG site |
PIF site |
DRS site |
DEF site |
EDI site |
MT3 site |
AAS site |
LBP site |
CMP site |
PDIG site |
ATP site |
PMP site |
Total Druggable Structures per Site |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
1U5R
|
13 |
3 |
0 |
20 |
0 |
0 |
11 |
0 |
0 |
7 |
17 |
10 |
0 |
AFQ9JLS3
|
0 |
15 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2GCD
|
11 |
6 |
0 |
16 |
0 |
0 |
3 |
0 |
0 |
0 |
16 |
14 |
0 |
1U5Q
|
6 |
3 |
0 |
15 |
0 |
0 |
10 |
0 |
0 |
8 |
18 |
4 |
0 |